WaveMan · Form 4
Nelsen Robert insider trades
> Search tickers & screens ⌘K
LIVE

Nelsen Robert insider trades

Nelsen Robert has filed 46 Form 4s with the SEC that we hold, for Vir Biotechnology, Inc. (VIR) (Director), Sana Biotechnology, Inc. (SANA) (Director, 10% owner), Prime Medicine, Inc. (PRME) (Director, 10% owner) and Lyell Immunopharma, Inc. (LYEL) (Director, 10% owner), among 8 companies in all. Across all of them we count 15 purchases worth $91.2M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($20.0M) and 0 sales ($0). The largest single trade was a purchase of 1,500,000 shares of Neumora Therapeutics, Inc. worth $25.5M, dated 2023-09-19. The first filing on our record is dated 2021-07-06 and the latest 2026-06-24.

Vir Biotechnology, Inc. (VIR)

Director · 15 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Sana Biotechnology, Inc. (SANA)

Director, 10% owner · 11 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-02-08P, purchase reported on Form 4727,272$4.0M2024-02-12
2024-02-08P, purchase reported on Form 4363,637$2.0M2024-02-12

Prime Medicine, Inc. (PRME)

Director, 10% owner · 8 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-10-24P, purchase reported on Form 4400,000$6.8M2022-10-26
2024-02-15P, purchase reported on Form 43,200,000$20.0M2024-02-20
2025-08-01P, purchase reported on Form 43,030,300$10.0M2025-08-01

Lyell Immunopharma, Inc. (LYEL)

Director, 10% owner · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Neumora Therapeutics, Inc. (NMRA)

10% owner · 4 filings · 9 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-09-19P, purchase reported on Form 41,500,000$25.5M2023-09-20
2023-09-22P, purchase reported on Form 440,000$445.6K2023-09-25
2023-09-25P, purchase reported on Form 430,773$332.3K2023-09-25
2023-09-25P, purchase reported on Form 429,967$349.1K2023-09-25
2023-09-26P, purchase reported on Form 434,000$398.8K2023-09-27
2023-09-27P, purchase reported on Form 424,504$301.6K2023-09-27
2023-09-28P, purchase reported on Form 416,841$219.9K2023-09-29
2023-09-28P, purchase reported on Form 425,110$343.8K2023-09-29
2023-09-29P, purchase reported on Form 434,560$483.1K2023-09-29

Kardigan, Inc. (KARD)

Director, 10% owner · 2 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-06-22P, purchase reported on Form 41,250,000$20.0M2026-06-24

DALS

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Rapport Therapeutics, Inc. (RAPP)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1219042) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms